A retrospective analysis of intramural NCI prostate cancer trials: Progress made and insights gleaned. Background: To date, docetaxel (D) is the only chemotherapy agent that has provided a survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback